Stanley Gibbons
SGI
$64.71
+0.70%
Somnigroup International Inc. is a global bedding company that designs, manufactures, distributes, and retails sleep solutions under iconic brands such as Tempur-Pedic, Sealy, and Stearns & Foster, operating in over 100 countries. As the parent of Mattress Firm and a leading player in the furnishings, fixtures, and appliances industry, it holds a dominant position in the mattress market with a vertically integrated omnichannel platform. The current investor narrative centers on the company's post-acquisition integration of Mattress Firm, which has driven revenue growth but also elevated leverage, while recent price declines reflect concerns over debt levels and consumer demand in a cyclical sector. The stock is under pressure despite a strong buy consensus, with analysts focusing on the company's ability to deleverage and sustain margin expansion.…
SGI
Stanley Gibbons
$64.71
Related headlines
Investment Opinion: Should I buy SGI Today?
Based on the analysis, I rate SGI as a Buy. The company's strong revenue growth, improving margins, and analyst consensus of Strong Buy with an average target of $89.44 (38.2% upside) support a positive outlook. The forward PE of 18.02 suggests the market expects significant earnings growth, which is plausible given the Mattress Firm synergies.
Sign up to view all
SGI 12-Month Price Forecast
The AI assessment is bullish with medium confidence. The company's strong growth and improving margins are positive, but high leverage and valuation premium introduce uncertainty. The forward PE suggests the market expects significant earnings growth, which is plausible if integration synergies materialize. Key developments to watch include quarterly earnings, debt reduction progress, and consumer spending trends. An upgrade to high confidence would occur if revenue growth accelerates and leverage declines; a downgrade would occur if margins compress or debt levels rise.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Stanley Gibbons's 12-month outlook, with a consensus price target around $89.44 and implied upside of +38.2% versus the current price.
Average Target
$89.44
0 analysts
Implied Upside
+38.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$66 - $105
Analyst target range
The stock has coverage from 9 analysts, with a consensus recommendation of 'Strong Buy' (mean rating of 1.4). The average target price is $89.44, implying an upside of 38.2% from the current price of $64.71. The distribution includes 8 Buy ratings and 1 Hold, with no Sells, indicating a bullish sentiment. The target range is from $66.00 (low) to $105.00 (high). The high target suggests that analysts expect a significant recovery, possibly driven by successful integration and margin expansion, while the low target is only 2% above the current price, reflecting downside risk if the company fails to meet expectations. Recent ratings actions show upgrades, such as Jefferies moving from Hold to Buy in March 2026, and UBS reiterating Buy, indicating growing confidence. The wide spread between low and high targets (39.4% difference) suggests high uncertainty about the company's future performance, likely due to leverage and cyclicality.
Bulls vs Bears: SGI Investment Factors
The bull case is anchored by robust revenue growth from the Mattress Firm acquisition, improving margins, and strong analyst support with a 38% upside to the average target. However, the bear case highlights high leverage, a premium valuation, and liquidity concerns that could amplify downside in a downturn. Currently, the evidence slightly favors the bulls due to the strong growth trajectory and operational improvements, but the high debt load and valuation premium create significant risk. The key tension is whether the company can deleverage and sustain margin expansion to justify its valuation, or if cyclical pressures and integration challenges will undermine the thesis.
Bullish
- Strong Revenue Growth from Mattress Firm Integration: Revenue grew 12.26% YoY in Q1 2026 to $1.80B, following 54.7% and 63.3% YoY growth in Q4 and Q3 2025, driven by the Mattress Firm acquisition. This expansion has transformed the company into a vertically integrated omnichannel leader.
- Improving Operating Margins: Operating margin improved to 11.52% in Q1 2026 from 9.57% in Q2 2025, indicating operational leverage from integration synergies. Gross margin remained stable at 43.61%, supporting profitability.
- Analyst Consensus Strong Buy with High Upside: With a mean rating of 1.4 (Strong Buy) and an average target of $89.44, the stock offers 38.2% upside from the current price of $64.71. Recent upgrades from Jefferies and UBS reinforce positive sentiment.
- Positive Free Cash Flow Generation: TTM free cash flow stands at $736.8M, with Q1 2026 FCF of $186M, providing capacity to service debt and fund growth initiatives. This supports deleveraging efforts.
Bearish
- High Leverage and Debt Burden: Debt-to-equity ratio is 2.66, and interest expense was $60M in Q1 2026. The elevated leverage increases financial risk, especially if cash flows weaken.
- Premium Valuation vs. Peers: Trailing PE of 48x is 118% above the industry average of 22x, and above its own historical range (18.2x-36.96x). This leaves little room for error if growth disappoints.
- Liquidity Concerns: Current ratio of 0.83 indicates potential difficulty covering short-term obligations, which could strain operations if access to credit tightens.
- Significant Underperformance vs. Market: The stock is down 19.6% over the past year and 29.0% over six months, while the S&P 500 gained 20.5% and 11.1% respectively, showing persistent negative relative strength.
SGI Technical Analysis
The stock is in a clear downtrend, with a 1-year price change of -19.61% and a 6-month decline of -29.05%. Currently trading at $64.71, it sits near the lower end of its 52-week range, at approximately 65.7% of the range (calculated from the low of $60.39 and high of $98.56). This positioning near the lows suggests bearish sentiment and potential value opportunity, but also risk of further downside if support fails. The stock's beta of 1.194 indicates slightly higher volatility than the market, amplifying both gains and losses.
Beta
1.19
1.19x market volatility
Max Drawdown
-37.3%
Largest decline past year
52-Week Range
$60-$99
Price range past year
Annual Return
-19.6%
Cumulative gain past year
| Period | SGI Return | S&P 500 |
|---|---|---|
| 1m | -7.7% | +3.6% |
| 3m | -3.3% | +2.7% |
| 6m | -29.0% | +11.4% |
| 1y | -19.6% | +18.7% |
| ytd | -27.1% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SGI Fundamental Analysis
Revenue growth has been robust, with the most recent quarter (Q1 2026) showing revenue of $1.8015 billion, up 12.26% year-over-year. This follows a trend of accelerating growth, as Q4 2025 revenue was $1.8684 billion (up from $1.2079 billion in Q4 2024, a 54.7% increase), and Q3 2025 revenue was $2.1226 billion (up from $1.3000 billion in Q3 2024, a 63.3% increase). The growth is largely driven by the Mattress Firm acquisition, which expanded the company's retail footprint. However, the growth rate may moderate as integration synergies are realized. The company is profitable, with net income of $104.2 million in Q1 2026, and gross margin of 43.61%, which is stable compared to prior quarters (44.93% in Q4 2025, 44.89% in Q3 2025). Operating margin improved to 11.52% in Q1 2026 from 9.57% in Q2 2025, indicating operational leverage. The balance sheet shows high leverage with a debt-to-equity ratio of 2.66, and current ratio of 0.83, indicating potential liquidity strain. Free cash flow was $186 million in Q1 2026, and TTM FCF is $736.8 million, which helps service debt but may limit flexibility.
Quarterly Revenue
$1.8B
2026-03
Revenue YoY Growth
+12.3%
YoY Comparison
Gross Margin
43.6%
Latest Quarter
Free Cash Flow
$736800000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SGI Overvalued?
Given that net income is positive, the PE ratio is the primary valuation metric. The trailing PE is 48.0, while the forward PE is 18.02, implying the market expects significant earnings growth. The gap between trailing and forward PE suggests that the market is pricing in a substantial increase in EPS, likely from the Mattress Firm synergies and cost savings. Compared to the industry average, the stock's PE of 48x is at a premium to the sector average of 22x (as per industry data), a 118% premium. This premium may be justified by the company's strong growth prospects and market leadership, but it also leaves little room for error. Historically, the stock's PE has ranged from 18.2x (Q3 2024) to 36.96x (Q1 2026), and the current trailing PE of 48x is above the historical range, indicating that the stock is trading at a premium to its own history, which could signal overvaluation if growth does not materialize as expected.
PE
48.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 16x~37x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are substantial. The debt-to-equity ratio of 2.66 indicates high leverage, and interest expense of $60M in Q1 2026 consumes a significant portion of operating income. The current ratio of 0.83 suggests potential liquidity strain, which could limit flexibility in a downturn. While free cash flow of $736.8M TTM provides some cushion, the company's ability to service debt depends on sustained revenue growth and margin stability. Revenue concentration in the mattress market and integration risks from the Mattress Firm acquisition add operational uncertainty.
FAQ
The key risks include: 1) Financial risk from high leverage (debt-to-equity 2.66) and liquidity concerns (current ratio 0.83). 2) Market risk from a premium valuation (trailing PE 48x) that could compress if growth slows. 3) Competitive risk from online mattress brands and changing consumer preferences. 4) Macro risk from economic cyclicality, as a downturn could reduce demand for big-ticket items. The most severe risk is a combination of these factors leading to a significant decline, potentially to the 52-week low of $60.39 or lower.
The 12-month forecast is bullish, with a base case target of $80-90 (50% probability), a bull case of $90-105 (30% probability), and a bear case of $60-70 (20% probability). The most likely scenario is the base case, where the company achieves moderate growth and margin expansion, leading to a stock price around the analyst average of $89.44. The key assumption is that the Mattress Firm integration continues to deliver synergies and that consumer demand remains stable.
On a trailing basis, SGI is overvalued with a PE of 48x, well above the industry average of 22x and its own historical range. However, on a forward basis, the PE of 18.02 suggests the market expects significant earnings growth, which could justify the premium if realized. The stock is trading at a discount to its 52-week high of $98.56, and the analyst average target implies a 38% upside. Overall, the valuation is rich but not unreasonable if the company meets growth expectations.
SGI offers a compelling risk/reward with a 38.2% upside to the analyst average target of $89.44, supported by strong revenue growth and improving margins. However, the high debt-to-equity ratio of 2.66 and premium valuation (trailing PE 48x) pose significant risks. It could be a good buy for investors with a higher risk tolerance and a long-term horizon, provided they are comfortable with potential volatility. The stock is currently near its 52-week low, offering a potential entry point, but only if the company can execute on its integration and deleveraging plans.
SGI is more suitable for long-term investment, given its growth potential and the time needed for integration synergies to materialize. The stock's beta of 1.194 indicates higher volatility, making it less ideal for short-term trading. The company pays a small dividend (yield 0.69%), but the primary return driver is capital appreciation. A minimum holding period of 3-5 years is recommended to allow the company to deleverage and realize the full benefits of the Mattress Firm acquisition.